Bonello Michael J. 4/A
4/A · PRA Health Sciences, Inc. · Filed Jun 30, 2021
Insider Transaction Report
Form 4/AAmended
Bonello Michael J.
Exec VP & CFO
Transactions
- Sale
Common Stock
2021-06-16$167.47/sh−600$100,482→ 4,675 total - Sale
Common Stock
2021-06-16$168.19/sh−195$32,797→ 4,480 total - Sale
Common Stock
2021-06-16$166.43/sh−6,589$1,096,607→ 5,275 total
Footnotes (5)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $166.07 to $166.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2), (3) and (4) of this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $167.11 to $167.96, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $168.11 to $168.26, inclusive.
- [F5]The number of shares reported in Column 5 reflects the number of shares beneficially owned by the reporting person as of the filing date of this Form 4, which reflects the transactions reported on the Form 4 filed by the reporting person on June 21, 2021.